r 59022 has been researched along with Glioblastoma in 1 studies
R 59022: diacylglycerol kinase inhibitor; structure given in first source; platelet activator factor antagonist
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dominguez, CL | 1 |
| Floyd, DH | 1 |
| Xiao, A | 1 |
| Mullins, GR | 1 |
| Kefas, BA | 1 |
| Xin, W | 1 |
| Yacur, MN | 1 |
| Abounader, R | 1 |
| Lee, JK | 1 |
| Wilson, GM | 1 |
| Harris, TE | 1 |
| Purow, BW | 1 |
1 other study available for r 59022 and Glioblastoma
| Article | Year |
|---|---|
Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers.
Topics: Apoptosis; Brain Neoplasms; Cell Line, Tumor; Diacylglycerol Kinase; Gene Expression Regulation, Neo | 2013 |